Liming Gui

753 total citations · 1 hit paper
15 papers, 553 citations indexed

About

Liming Gui is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Liming Gui has authored 15 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Liming Gui's work include Immunotherapy and Immune Responses (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and CAR-T cell therapy research (2 papers). Liming Gui is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and CAR-T cell therapy research (2 papers). Liming Gui collaborates with scholars based in China, United States and Hong Kong. Liming Gui's co-authors include Wei‐Qiang Gao, Xing‐Zhi Yang, Yuhan Zhao, Yang Xu, Juan Wang, Xiao‐Jiang Hao, Jimin Fei, Shun‐Lin Li, Yueqin Zhao and Yinyuan Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Molecular Therapy.

In The Last Decade

Liming Gui

14 papers receiving 550 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells

2021 302 citations Yueqin Zhao, Juan Wang et al. International Journal of Biological Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liming Gui China	9	322	238	202	114	102	15	553
Hironari Nishizawa Japan	11	445 1.4×	337 1.4×	243 1.2×	84 0.7×	55 0.5×	20	672
Linlin Lou China	7	297 0.9×	212 0.9×	170 0.8×	104 0.9×	66 0.6×	10	483
Tianbo Xu China	19	512 1.6×	324 1.4×	305 1.5×	112 1.0×	70 0.7×	27	728
Rongkun Li China	15	420 1.3×	99 0.4×	260 1.3×	111 1.0×	99 1.0×	25	589
Juanni Li China	16	605 1.9×	141 0.6×	405 2.0×	112 1.0×	76 0.7×	39	814
Meisongzhu Yang China	12	386 1.2×	114 0.5×	220 1.1×	104 0.9×	63 0.6×	16	524
Lin Zhong China	9	304 0.9×	221 0.9×	220 1.1×	111 1.0×	43 0.4×	21	523
Daniela Frezzetti Italy	13	358 1.1×	110 0.5×	266 1.3×	175 1.5×	59 0.6×	18	613
Tasnuva D. Kabir Australia	9	291 0.9×	117 0.5×	232 1.1×	75 0.7×	65 0.6×	12	546

Countries citing papers authored by Liming Gui

Since Specialization

Citations

This map shows the geographic impact of Liming Gui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liming Gui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liming Gui more than expected).

Fields of papers citing papers by Liming Gui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liming Gui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liming Gui. The network helps show where Liming Gui may publish in the future.

Co-authorship network of co-authors of Liming Gui

This figure shows the co-authorship network connecting the top 25 collaborators of Liming Gui. A scholar is included among the top collaborators of Liming Gui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liming Gui. Liming Gui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Aji, Rebiguli, Yue Xu, Ziyi Wang, et al.. (2025). Targeted delivery of Grem1 and IL-10 separately by mesenchymal stem cells effectively mitigates SETD2-deficient inflammatory bowel disease. Theranostics. 15(6). 2215–2228. 2 indexed citations

Gui, Liming, Kaiwen Chen, Jingjing Yan, et al.. (2025). Targeting the mevalonate pathway potentiates NUAK1 inhibition-induced immunogenic cell death and antitumor immunity. Cell Reports Medicine. 6(2). 101913–101913. 8 indexed citations

Li, Ni, Xiaoxue Li, Yiwen Zhu, et al.. (2023). SETD2 deficiency promotes renal fibrosis through the TGF‐β/Smad signalling pathway in the absence of VHL. Clinical and Translational Medicine. 13(11). e1468–e1468. 4 indexed citations

Gui, Liming, Zhixue Wang, Weihua Lou, et al.. (2023). Comparative evaluation of antitumor effects of TNF superfamily costimulatory ligands delivered by mesenchymal stem cells. International Immunopharmacology. 126. 111249–111249. 3 indexed citations

Yang, Qing, Hui Du, Xinfeng Qu, et al.. (2022). Comparison of cycle threshold values of the Cobas HPV test and viral loads of the BMRT HPV test in cervical cancer screening. Frontiers in Public Health. 10. 1010066–1010066.

Wang, Zhixue, et al.. (2022). Dendritic cell-targeting chemokines inhibit colorectal cancer progression. SHILAP Revista de lepidopterología. 3(6). 828–840. 5 indexed citations

Zhao, Yueqin, Juan Wang, Yang Xu, et al.. (2021). Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells. International Journal of Biological Sciences. 17(11). 2703–2717. 302 indexed citations breakdown →

Liu, Min, Xiaoxue Li, Liming Gui, et al.. (2021). The histone methyltransferase SETD2 modulates oxidative stress to attenuate experimental colitis. Redox Biology. 43. 102004–102004. 35 indexed citations

Li, Xiaoxue, Changwei Liu, Min Liu, et al.. (2021). SETD2 epidermal deficiency promotes cutaneous wound healing via activation of AKT/mTOR Signalling. Cell Proliferation. 54(6). e13045–e13045. 19 indexed citations

10.

Yan, Jingjing, et al.. (2021). CCL28 Downregulation Attenuates Pancreatic Cancer Progression Through Tumor Cell-Intrinsic and -Extrinsic Mechanisms. Technology in Cancer Research & Treatment. 20. 2203810846–2203810846. 10 indexed citations

11.

Hui, Lanlan, Deng Wang, Zhao Liu, et al.. (2021). The Cell‐Isolation Capsules with Rod‐Like Channels Ensure the Survival and Response of Cancer Cells to Their Microenvironment. Advanced Healthcare Materials. 11(2). e2101723–e2101723. 3 indexed citations

12.

Qian, Weijun, Liming Gui, Zhongzhong Ji, et al.. (2020). Blockade of β-Catenin–Induced CCL28 Suppresses Gastric Cancer Progression via Inhibition of Treg Cell Infiltration. Cancer Research. 80(10). 2004–2016. 84 indexed citations

13.

Gui, Liming, Caihong Wang, Jingjing Yan, et al.. (2020). Targeted Delivery of CXCL9 and OX40L by Mesenchymal Stem Cells Elicits Potent Antitumor Immunity. Molecular Therapy. 28(12). 2553–2563. 33 indexed citations

14.

Wang, Caihong, et al.. (2020). β-Catenin inhibition shapes tumor immunity and synergizes with immunotherapy in colorectal cancer. OncoImmunology. 9(1). 1809947–1809947. 29 indexed citations

15.

Gui, Liming, et al.. (2005). Tumorigenesis of K-ras mutation in human endometrial carcinoma via upregulation of estrogen receptor. Gynecologic Oncology. 101(2). 274–279. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact